Dr. Mammen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4940 Eastern Avenue
Baltimore, MD 21224Phone+1 410-550-6962- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 2004 - 2005
- Johns Hopkins UniversityResidency, Neurology, 2001 - 2004
- Johns Hopkins UniversityInternship, Internal Medicine, 2000 - 2001
- Johns Hopkins University School of MedicineClass of 2000
Certifications & Licensure
- MD State Medical License 2004 - 2025
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Publications & Presentations
PubMed
- Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy.Sandra Donkervoort, Payam Mohassel, Melanie O'Leary, Devon E Bonner, Taila Hartley, Nicole Acquaye, Astrid Brull, Tahseen Mozaffar, Mario A Saporta, David A Dyment, Ja...> ;Annals of Clinical and Translational Neurology. 2024 Mar 1
- Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies.Jiram Torres-Ruiz, Iago Pinal-Fernandez, Albert Selva-O'Callaghan, Bianca Campbell, Sandra Muñoz-Braceras, Nancy R Mejía-Domínguez, Carlos Núñez-Álvarez, José Milisend...> ;Clinical and Experimental Rheumatology. 2024 Feb 1
- Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank.Aravinthan Loganathan, Giovanni Zanframundo, Akira Yoshida, Sara Faghihi-Kashani, Iazsmin Bauer Ventura, Eduardo Dourado, Francisca Bozan, Gianluca Sambataro, Yasuhiko...> ;Clinical and Experimental Rheumatology. 2024 Feb 1
- Join now to see all
Press Mentions
- Ra Pharmaceuticals Announces Expansion of Neuromuscular Portfolio with Clearance of IND Application for Zilucoplan for the Treatment of Immune-Mediated Necrotizing MyopathyJune 4th, 2019
- Update on MyositisOctober 25th, 2018
- Atorvastatin-Induced Necrotizing Autoimmune Myositis: An Emerging Dominant Entity in Patients with Autoimmune Myositis Presenting with a Pure Polymyositis PhenotypeJanuary 23rd, 2017
- Join now to see all
Professional Memberships
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/andrew-mammen
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: